Gentian Diagnostics AS (GENT) — Cash Flow Reinvestment Rate
Gentian Diagnostics AS (GENT) has a Cash Flow Reinvestment Rate of 0.25x as of December 2025, reinvesting Nkr10.76 Million (capex Nkr10.76 Million ) from operating cash flow of Nkr42.59 Million. Check Gentian Diagnostics AS cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Gentian Diagnostics AS Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Gentian Diagnostics AS across 4 annual periods. Explore GENT debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Gentian Diagnostics AS (2013–2025)
Year-by-year capital reinvestment analysis for Gentian Diagnostics AS. For live market cap and broader valuation context, see how much is Gentian Diagnostics AS worth.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | Nkr10.76 Million | Nkr42.59 Million | Nkr10.76 Million | ▼ -84.5% |
| 2024 | 1.63x | Nkr21.90 Million | Nkr13.46 Million | Nkr10.95 Million | ▲ +147.8% |
| 2023 | 0.66x | Nkr10.15 Million | Nkr15.46 Million | Nkr4.49 Million | ▼ -54.2% |
| 2013 | 1.44x | Nkr3.49 Million | Nkr2.43 Million | Nkr3.49 Million | — |